Cargando…
Correction to: A Phase I Study to Evaluate the Pharmacokinetics and Safety of Lorlatinib in Adults with Mild, Moderate, and Severe Renal Impairment
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9050760/ https://www.ncbi.nlm.nih.gov/pubmed/35258796 http://dx.doi.org/10.1007/s13318-022-00759-8 |
| _version_ | 1784696439951065088 |
|---|---|
| author | Lin, Swan Gong, Jason Canas, George C. Winkle, Peter Pelletier, Kathleen LaBadie, Robert R. Ginman, Katherine Pithavala, Yazdi K. |
| author_facet | Lin, Swan Gong, Jason Canas, George C. Winkle, Peter Pelletier, Kathleen LaBadie, Robert R. Ginman, Katherine Pithavala, Yazdi K. |
| author_sort | Lin, Swan |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9050760 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Springer International Publishing |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-90507602022-05-07 Correction to: A Phase I Study to Evaluate the Pharmacokinetics and Safety of Lorlatinib in Adults with Mild, Moderate, and Severe Renal Impairment Lin, Swan Gong, Jason Canas, George C. Winkle, Peter Pelletier, Kathleen LaBadie, Robert R. Ginman, Katherine Pithavala, Yazdi K. Eur J Drug Metab Pharmacokinet Correction Springer International Publishing 2022-03-08 2022 /pmc/articles/PMC9050760/ /pubmed/35258796 http://dx.doi.org/10.1007/s13318-022-00759-8 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/ Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
| spellingShingle | Correction Lin, Swan Gong, Jason Canas, George C. Winkle, Peter Pelletier, Kathleen LaBadie, Robert R. Ginman, Katherine Pithavala, Yazdi K. Correction to: A Phase I Study to Evaluate the Pharmacokinetics and Safety of Lorlatinib in Adults with Mild, Moderate, and Severe Renal Impairment |
| title | Correction to: A Phase I Study to Evaluate the Pharmacokinetics and Safety of Lorlatinib in Adults with Mild, Moderate, and Severe Renal Impairment |
| title_full | Correction to: A Phase I Study to Evaluate the Pharmacokinetics and Safety of Lorlatinib in Adults with Mild, Moderate, and Severe Renal Impairment |
| title_fullStr | Correction to: A Phase I Study to Evaluate the Pharmacokinetics and Safety of Lorlatinib in Adults with Mild, Moderate, and Severe Renal Impairment |
| title_full_unstemmed | Correction to: A Phase I Study to Evaluate the Pharmacokinetics and Safety of Lorlatinib in Adults with Mild, Moderate, and Severe Renal Impairment |
| title_short | Correction to: A Phase I Study to Evaluate the Pharmacokinetics and Safety of Lorlatinib in Adults with Mild, Moderate, and Severe Renal Impairment |
| title_sort | correction to: a phase i study to evaluate the pharmacokinetics and safety of lorlatinib in adults with mild, moderate, and severe renal impairment |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9050760/ https://www.ncbi.nlm.nih.gov/pubmed/35258796 http://dx.doi.org/10.1007/s13318-022-00759-8 |
| work_keys_str_mv | AT linswan correctiontoaphaseistudytoevaluatethepharmacokineticsandsafetyoflorlatinibinadultswithmildmoderateandsevererenalimpairment AT gongjason correctiontoaphaseistudytoevaluatethepharmacokineticsandsafetyoflorlatinibinadultswithmildmoderateandsevererenalimpairment AT canasgeorgec correctiontoaphaseistudytoevaluatethepharmacokineticsandsafetyoflorlatinibinadultswithmildmoderateandsevererenalimpairment AT winklepeter correctiontoaphaseistudytoevaluatethepharmacokineticsandsafetyoflorlatinibinadultswithmildmoderateandsevererenalimpairment AT pelletierkathleen correctiontoaphaseistudytoevaluatethepharmacokineticsandsafetyoflorlatinibinadultswithmildmoderateandsevererenalimpairment AT labadierobertr correctiontoaphaseistudytoevaluatethepharmacokineticsandsafetyoflorlatinibinadultswithmildmoderateandsevererenalimpairment AT ginmankatherine correctiontoaphaseistudytoevaluatethepharmacokineticsandsafetyoflorlatinibinadultswithmildmoderateandsevererenalimpairment AT pithavalayazdik correctiontoaphaseistudytoevaluatethepharmacokineticsandsafetyoflorlatinibinadultswithmildmoderateandsevererenalimpairment |